Search
Filter your results
- All
- News
- Opinion
- Commentary
- Media Miss
Bitcoin begins to stabilize following weekend sell-off
Bitcoin dropped by almost 5% on Monday after a bruising weekend when, at one point, it lost over a fifth of its value. It’s now trading at roughly $49,200, down from about $57,000 at the beginning of December. Traders said the fall was connected to a broad move away from riskier assets in traditional markets…
Slow and steady? November jobs report shows sluggish growth
With only 210,000 jobs added in November, America’s employers saw the slowest hiring pace in nearly a year. In the monthly jobs report, the Labor Department also noted that the unemployment rate dipped from 4.6% to 4.2%, proof that many people reported they had a job. President Joe Biden played up the drop in the…
Zoom, Peloton not the only stocks to see Omicron boost after COVID variant news
The news of a new COVID-19 variant had the stock market seeing red this past week, but some stocks actually got an Omicron boost while the rest of the market got spooked. #5: Stay-at-home stocks Two of the stock market’s favorite pandemic plays, Zoom and Peloton, have had a rough go with reopening. But both…
Biden announces strategy to fight COVID-19 as winter approaches
Looking to avoid what happened last winter, President Joe Biden announced his administration’s strategy to address COVID-19 this winter. According to the New York Times, the United States’ 7-day average for new cases peaked at over 250,000 this past January. Weekly applications for unemployment benefits also peaked at around this time at over 900,000. “Just…
How is the new ‘Omicron’ COVID variant pronounced? No one knows.
Health experts, world leaders, and news anchors have all been flubbing the pronunciation of Omicron, the latest COVID-19 variant. On Nov. 26, Dr. Maria Van Kerkhove, a COVID technical lead at the World Health Organization, announced to the world the newest COVID-19 variant and pronounced it “Oh-my-kraan.” Three days later, President Joe Biden gave a briefing…
“It was just a matter of time”: First US case of Omicron COVID-19 variant detected
The California and San Francisco Departments of Public Health released a joint statement Wednesday announcing the first case of the Omicron variant of COVID-19 detected in the United States. According to the statement, “the University of California, San Francisco identified this case through their sequencing capabilities.” “California is continuing to monitor the variant’s presence and…
CDC tightening COVID-19 testing requirements for travelers, courts block vaccine mandates
On the same day federal judges in two different courts blocked two different Biden administration COVID-19 vaccine mandates, The Centers for Disease Control and Prevention (CDC) announced Tuesday it was working on tightening its current testing requirements for international travelers. Currently, fully vaccinated travelers are required to get tested within three days of boarding. “CDC is…
WHO skips “Nu” and “Xi” to name new Omicron COVID-19 variant
The World Health Organization announced a new and potentially more dangerous COVID-19 variant spreading across the globe called Omicron. Here’s how WHO named this variant. In May, WHO announced it would use the Greek alphabet to name new COVID-19 variants, a practice once used by The National Hurricane Center when naming hurricanes. Since implementing the…
FDA panel approves Merck COVID-19 pill, sets stage for authorization
In a narrow Tuesday afternoon vote of 13-10, an advisory panel to the Food and Drug Administration (FDA) approved Merck’s COVID-19 pill. Molnupiravir is an oral antiviral drug initially hailed as a potential game changer in the battle against Covid since it can be taken at home instead of at a hospital like other treatments.…
Wall Street, consumer confidence tumble amid Omicron variant concerns
Stocks fell on Wall Street at the start of trading Tuesday, amid new details regarding the Omicron variant. Those details included comments from Moderna CEO Stephane Bancel, who told the Financial Times he expected current vaccines would struggle with the variant. “There is no world, I think, where [the effectiveness] is the same level . . . we…
Welcome back to trustworthy journalism.
Here at Straight Arrow News, we…
Report without partisan spin, earning distinctions from media bias experts at AllSides and Ad Fontes
Share what other news outlets are underreporting with our Media Miss™ tool
Provide perspective with opinions and commentary from all sides